Profound Medical Corp. (TSX:PRN)

Profound Medical Statistics

Total Valuation

TSX:PRN has a market cap or net worth of CAD 271.98 million. The enterprise value is 230.54 million.

Market Cap	271.98M
Enterprise Value	230.54M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:PRN has 30.05 million shares outstanding. The number of shares has increased by 20.83% in one year.

Current Share Class	30.05M
Shares Outstanding	30.05M
Shares Change (YoY)	+20.83%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	8.39%
Owned by Institutions (%)	51.43%
Float	27.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.84
PB Ratio	5.08
P/TBV Ratio	5.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.15
EV / Sales	14.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.12.

Current Ratio	8.53
Quick Ratio	7.00
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.78% and return on invested capital (ROIC) is -58.80%.

Return on Equity (ROE)	-103.78%
Return on Assets (ROA)	-53.05%
Return on Invested Capital (ROIC)	-58.80%
Return on Capital Employed (ROCE)	-96.29%
Revenue Per Employee	113,719
Profits Per Employee	-391,207
Employee Count	142
Asset Turnover	0.24
Inventory Turnover	0.48

Taxes

In the past 12 months, TSX:PRN has paid 60,010 in taxes.

Income Tax	60,010
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.54% in the last 52 weeks. The beta is 0.36, so TSX:PRN's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-12.54%
50-Day Moving Average	6.81
200-Day Moving Average	8.14
Relative Strength Index (RSI)	76.77
Average Volume (20 Days)	28,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:PRN had revenue of CAD 16.15 million and -55.55 million in losses. Loss per share was -2.01.

Revenue	16.15M
Gross Profit	11.21M
Operating Income	-57.71M
Pretax Income	-55.49M
Net Income	-55.55M
EBITDA	-56.68M
EBIT	-57.71M
Loss Per Share	-2.01

Balance Sheet

The company has 48.00 million in cash and 6.56 million in debt, giving a net cash position of 41.44 million or 1.38 per share.

Cash & Cash Equivalents	48.00M
Total Debt	6.56M
Net Cash	41.44M
Net Cash Per Share	1.38
Equity (Book Value)	53.54M
Book Value Per Share	1.78
Working Capital	58.76M

Cash Flow

Operating Cash Flow	-47.37M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	69.43%
Operating Margin	-357.39%
Pretax Margin	-343.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:PRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.83%
Shareholder Yield	n/a
Earnings Yield	-20.42%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 16, 2019
Split Type	Reverse
Split Ratio	0.1

Scores

TSX:PRN has an Altman Z-Score of 2.15 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.15
Piotroski F-Score	3